Executive Director, Biostatistics Exelixis IncExecutive Director, BiostatisticsAlameda, CAKnowledge/Skills: • Strong people management and interpersonal skills • Strong communication skills • Strong conflict management skills • Comprehensive and detailed knowledge of statistical experimental designs, analyses, and clinical trial requirements, particularly pertaining to oncology trials. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: • MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 16 years of related experience; or, • PhD in Statistics/Biostatistics or related discipline and a minimum of 15 years of related experience; or, • Equivalent combination of education and relevant experience in oncology.
Director, Biostatistics Tempus AI IncDirector, BiostatisticsRedwood City, CA$180,000–$240,000 / yearSalary Range: CHI: $180,000-$240,000 USD NYC/SF: $190,000-$260,000 The expected salary range above is applicable if the role is performed from California and may vary for other locations (Colorado, Illinois, New York). We are seeking a highly motivated and capable Director of Biostatistics to lead a team of biostatisticians involved in multiple aspects of clinical research at Tempus.
Assoc Biostatistics Director Exelixis IncAssoc Biostatistics DirectorAlameda, CA$166,500–$236,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in related discipline and a minimum of 9 years of related experience; or, PhD in related discipline and a minimum of 5 years of related experience; or, Equivalent combination of education and experience. Works collaboratively with clinicians, data managers, biostatisticians, statistical programmers, and medical writers in the planning, conduct and analysis of clinical trials.
Director, Biostatistics - Late Phase Revolution Medicines IncDirector, Biostatistics - Late PhaseRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Senior Director, Biostatistics - Late Phase Revolution Medicines IncSenior Director, Biostatistics - Late PhaseRedwood City, CA$244,000–$305,000 / yearThe Opportunity: Playing a critical role as a lead statistician for clinical Late-Stage program(s) and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to serve as a program level lead statistician and provide statistical leadership and support for clinical development strategy and programs through product life cycle. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Biostatistics - Early Phase Revolution Medicines IncAssociate Director, Biostatistics - Early PhaseRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Biostatistics - Early Phase Revolution Medicines IncDirector, Biostatistics - Early PhaseRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Director, Biostatistics - Early Phase Revolution MedicinesDirector, Biostatistics - Early PhaseRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a lead statistician for clinical program(s) and studies and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Associate Director, Biostatistics – Early Phase Revolution MedicinesAssociate Director, Biostatistics – Early PhaseRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Biostatistics Maze Therapeutics IncDirector, BiostatisticsSouth San Francisco, CA$228,000–$280,000 / yearThe company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
Associate Director/Director Biostatistics Structure Therapeutics IncAssociate Director/Director BiostatisticsSouth San Francisco, CA$201,000–$250,000 / yearAct as the primary study contact and provide oversight for all biostatistics related activities outsourced to CROs and external vendors Work closely with colleagues (Medical, Data Management, Statistical Programmers, Medical Writing, Safety, Clinical Operations, and Regulatory teams) to: Review protocols and prepare statistical methods section(s), including sample size estimation and clinical endpoint selection, to ensure Structure's conducts well designed, efficient, and cost-effective as well as statistically valid clinical trials Generate and/or review randomization schedule(s) to ensure high statistical quality of clinical protocols and analyses. Provides biostatistics support to Structure's expanding portfolios Provide statistical support for clinical study design, endpoint selection, sample size calculations, randomization schedules, statistical analysis plans (SAP) and data interpretation in collaboration with all team members, including programmers, data manager, medical writers and clinicians.
Director, Biostatistics Summit TherapeuticsDirector, BiostatisticsPalo Alto, CaliforniaHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Serves as the project level biostatistician and provides leadership within biostatistics function to develop and execute statistical strategy, study design, statistical analyses, and regulatory submissions for clinical trials in oncology.
Associate Director of Biostatistics Natera IncAssociate Director of BiostatisticsSan Carlos, CA$191,800–$239,800 / yearAs an Associate Director in Biostatistics, you will leverage your deep applied statistics and leadership background to guide the design and interpretation of Natera sponsored clinical studies ensuring scientific rigor and meaningful clinical insights across oncology programs. The Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other.
Principal Statistician, Biostatistics Jazz Pharmaceuticals PlcPrincipal Statistician, BiostatisticsPalo Alto, CARemote$132,000–$198,000 / yearKnowledge of clinical trial design and analysis, including experience with complex statistical methods and models, including statistical principles and methodology and principles of statistical inference, including hypothesis testing and deriving estimates, parametric and non-parametric models and techniques, principles of sample size calculations for comparing two arms, principles of design of experiments in introducing conditions designed to affect an outcome of interest, and phase II-IV clinical trial data analysis. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company''s Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz''s Long Term Equity Incentive Plan.
NewDirector/Senior Director, Biostatistics GalapagosDirector/Senior Director, BiostatisticsSan Francisco, CALakefront Biotherapeutics is a global biotech with offices in Belgium, Chicago and San Francisco, focused on building a differentiated immunology and inflammation pipeline to address serious diseases with high unmet medical need. This is a highly visible, cross-functional role in which you will own the statistical strategy for our clinical programs — from designing statistical strategy through data analysis, interpretation of results, and regulatory submission.
Biostatistics Manager Exelixis IncBiostatistics ManagerAlameda, CA$130,500–$186,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: BS/BA degree in related discipline and 7 years of related experience; or, MS/MA degree in related discipline and 5 years of related experience; or, PhD in related discipline and 0 or more years of related experience; or, Equivalent combination of education and experience. SUMMARY/JOB PURPOSE: Designs, plans and executes biostatistical components of plans for research and development projects that establish the conditions essential for determining safety, efficacy and marketability of compounds.
Associate Director, Biostatistics Lyell Immunopharma IncAssociate Director, BiostatisticsSouth San Francisco, CA$175,000–$200,000 / yearLyell's product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients.
Associate Director, Biostatistics Summit TherapeuticsAssociate Director, BiostatisticsPalo Alto, CaliforniaHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Review the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports.
Sr. Director, Biostatistics ALX Oncology Inc.Sr. Director, BiostatisticsSouth San Francisco, CA$240,000–$280,000The Senior Director will collaborate closely with Clinical Development, Translational Medicine, Biomarker Sciences, Regulatory Affairs, Data Management, Statistical Programming, Clinical Operations, and external partners. The successful candidate will play a critical role in advancing precision medicine strategies through innovative trial methodologies, biomarker-driven development, and global regulatory engagement.
NewDirector, Biostatistics - Remote Agios PharmaceuticalsDirector, Biostatistics - RemoteSan Francisco, CARemote$183,000–$275,000 / yearThe current base salary range for this position is expected to be between $183,000 and $275,000 annualized; final salary will be determined based on various factors including, but not limited to, years of relevant experience, job knowledge, skills and proficiency, degree/education, and internal comparators. The Director will serve as the lead statistician for assigned clinical development programs, leading the development and implementation of statistical solutions to support all phases of clinical trials, regulatory filing and facilitating decision-making.
Biostatistician 4 eTeam Inc.Biostatistician 4Sunnyvale, CA$80–$85 / hourAs a key member of the Clinical Affairs department, the Senior Biostatistician (Biostatistician IV) provides advanced statistical expertise to support the design, conduct, and analysis of clinical studies, ranging from early pre-market to post-market evidence generation. Data Analysis: Utilize appropriate and robust statistical and programming methodology in the analysis of clinical trial data, including complex and advanced methods as needed, ensuring high-quality results for regulatory submissions and scientific publications.
Biostatistician 2 Stanford UniversityBiostatistician 2Stanford, CA$115,103–$134,261 / yearKnowledge of, or ability to learn several commonly applied statistical methods such as hierarchical regression models with random intercepts and slopes, parametric survival models including accelerated failure time models, effect modification and moderation methods, understanding of the basic principles of risk adjustment within the CMS framework, econometric modeling for cost variables with highly skewed distributions, generalized linear models including repeated measures analysis, machine learning approaches such as XGBoost, Explainable Boosting Machines (EBMs), random forests, random survival forests, cluster analysis, latent class analysis, and other classification approaches. Demonstrated excellence in at least one area of expertise, which may include coordinating studies; statistical methodology such as missing data, survival analysis, statistical genetics, or informatics; statistical computing; database design (e.g., expertise in RedCAP or MySQL); graphical techniques (e.g., expertise in Illustrator).
Senior Biostatistician Genentech IncSenior BiostatisticianSouth San Francisco, CA$136,900–$254,200 / yearAs trusted analytical partners in end-to-end drug development, Biostatistics leverages data to drive scientifically rigorous programmatic decisions across Roche's Development portfolio; Biostatistics designs robust trials and analysis plans that increase the probability of technical success, accelerating timelines to advance Roche's clinical pipeline and promote regulatory success - ultimately bringing medicines to our patients faster. This role ensures the scientific rigor and regulatory compliance of the study by contributing to protocol development, authoring statistical analysis plans, performing or overseeing data analyses, and supporting the interpretation and communication of results.
Staff Biostatistician Analytical Validation Natera IncStaff Biostatistician Analytical ValidationSan Carlos, CA$180,400–$225,500 / yearThe Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other. As a Staff Biostatistician, you will leverage your strong applied statistics expertise to drive the strategy and execution of complex validation experiments for multiple high-priority projects.
Senior Biostatistician Intuitive Surgical IncSenior BiostatisticianSunnyvale, CACertain information you provide as part of the application will be used for purposes of determining whether Intuitive Surgical will need to (i) obtain an export license from the U.S. Government on your behalf (note: the government's licensing process can take 3 to 6+ months) or (ii) implement a Technology Control Plan ("TCP") (note: typically adds 2 weeks to the hiring process). U.S. Export Controls Disclaimer: In accordance with the U.S. Export Administration Regulations (15 CFR §743.13(b)), some roles at Intuitive Surgical may be subject to U.S. export controls for prospective employees who are nationals from countries currently on embargo or sanctions status.
Principal Biostatistician Genentech IncPrincipal BiostatisticianSouth San Francisco, CA$153,300–$284,700 / yearEarly Development Biometrics is also home to the Statistical Methodology group, which enables the most impactful use of quantitative methodology across PDD through internal consultation, external collaboration, and continuous capability building; and Visual Analytics, which creates and maintains interactive dashboards that drive high-quality Medical Data Review (MDR) and safety signal detection, aligned with Risk-Based Quality Management (RBQM) principles and Critical-to-Quality (CtQ) endpoints. As trusted partners in early development, we design efficient and innovative clinical trials, apply rigorous statistical methods, and implement high-quality programming and analytical solutions to accelerate timelines, de-risk development, and increase the probability of technical success.
Head of Clinical Pharmacology CytokineticsHead of Clinical PharmacologySouth San Francisco, CaliforniaThe Head of Clinical Pharmacology will serve as the subject matter expert for clinical pharmacology, pharmacokinetics (PK), pharmacodynamics (PD), PK/PD modeling and simulation, PBPK modeling, metabolic profiling, and exposure-response analyses, ensuring robust dose selection, characterization of drug-drug interaction profiles, , and regulatory alignment. Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
Medical Director, Clinical Development (Oncology) Allogene TherapeuticsMedical Director, Clinical Development (Oncology)South San Francisco, CARemote$255,000–$335,000 / yearEstablish cross-functional relationships with leaders from key cross-functional lines including Regulatory Affairs, Clinical Operations, Commercial, Program Management, etc. and leverage those relationships to manage key project issues including but not limited to Research, Development, Commercial, Manufacturing and Competitive Intelligence. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
Medical Director, Clinical Development (Oncology) Allogene Therapeutics IncMedical Director, Clinical Development (Oncology)South San Francisco, CARemote$255,000–$335,000 / yearEstablish cross-functional relationships with leaders from key cross-functional lines including Regulatory Affairs, Clinical Operations, Commercial, Program Management, etc. and leverage those relationships to manage key project issues including but not limited to Research, Development, Commercial, Manufacturing and Competitive Intelligence. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
Medical Director, Pharmacovigilance Allogene Therapeutics IncMedical Director, PharmacovigilanceSouth San Francisco, CA$255,000–$335,000 / yearLed by a management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. About Allogene: Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease.
Scientist, Product Development Natera IncScientist, Product DevelopmentSan Carlos, CA$116,800–$140,000 / yearThe Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other. You will build, validate, and troubleshoot next-generation sequencing (NGS) and cell-free DNA (cfDNA) assays used in liquid biopsy and Minimal Residual Disease (MRD) testing.
Decision Analytics Associate Consultant ZS Associates IncDecision Analytics Associate ConsultantSouth San Francisco, CAAs a management consulting and technology firm focused on improving life and how we live it, we transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. We work with our clients to go beyond delivering high quality studies, to helping them make sure the work they are undertaking are the right ones to support their strategic priorities, and even shape those priorities.
VP of Global Clinical Affairs Intuitive Surgical IncVP of Global Clinical AffairsSunnyvale, CACore competencies of this position include: Expert knowledge and understanding of all clinical specialties and technology platforms that Intuitive serves; Significant experience and proven success leading multiple teams in the medical device or related industry; Significant experience leading clinical affairs strategies and objectives; Ability to create departmental vision, strategy, and strategic objectives and guide teams in their execution; Establish effective programs, guidelines, and procedures for global clinical affairs activities. This leader will help support regulatory submissions and the generation of high-impact clinical evidence through publications, presentations, abstracts, and scientific collaborations that enable market access, adoption, and reimbursement worldwide.
Decision Analytics Associate Consultant - HEOR Evidence Generation ZSDecision Analytics Associate Consultant - HEOR Evidence GenerationSouth San Francisco, California